Last updated 2026-06-18
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$20.0M
total disclosed, rounds participated
Stages
—
Portfolio · 1
Investment activity
1 portfolio exit on record.
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is Finteca Holdings' most notable exit?
- Finteca Holdings exited Chemomab Therapeutics in March 2021 through a reverse merger with Anchiano Therapeutics, which then listed on NASDAQ.
- Which sector does Finteca Holdings primarily focus on for its investments and exits?
- Finteca Holdings shows a concentration in the Health Tech & Life Sciences sector, with both its portfolio companies and exits falling within this area.
- Can you name a key company in Finteca Holdings' portfolio?
- A key company in Finteca Holdings' portfolio is Chemomab Therapeutics, which focuses on innovative treatments for fibro-inflammatory-related diseases.
- When did Finteca Holdings make its most recent investment?
- Finteca Holdings made an investment in December 2019.
- What type of funding rounds has Finteca Holdings participated in?
- Finteca Holdings has participated in C Round funding stages.
- What is the total amount raised by Chemomab Therapeutics, a company in Finteca Holdings' portfolio?
- Chemomab Therapeutics has raised $90.5M.